2 new MIDOS signals
EXTREME
VIX 22.2 (88% ptl) · Position: 25%
ASND
ASCENDIS PHARMA
Health Care·Biotechnology·DENMARK
$213.23
MCap $13.2B
as of 2026-06-09
Total
B
1w
Fund
B
1w
Quant
C
1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.74
Sentiment 13.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$213.23
Adaptive Mean
$207.66
+5.57 vs mean
Adaptive σ
3.76
MIDOS BB
$200.13 – $215.18
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+1.14
ROE
Z
Rev Gr
144.3%
Z +0.92
EPS Gr
42.4%
Z +0.09
OPM Gr
109.7%
Z +0.40
FCF Yld
0.4%
Z +0.09
EPS Surp
3471.4%
Z +4.59
EPS 3mo Δ
53.5%
Z +0.73
Fwd P/E
19.64
Z
PEGY
0.46
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-9.90
Q6M
0.69
Q12M
2.57
MA 30/100
1.006
Bullish (MA30 > MA100)
α (Jensen)
-0.7637
β (12M)
0.33
σ (12M)
0.363
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
66%
Divergence
+32.6
Tier
RELOAD — WATCH
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
-2.7
RS Pctl
48%
RS Decile
D5
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.